|
Nanomaterials and health - Convegno Nanomateriali e Salute |
|
|
|
|
Written by Ivana Fenoglio
|
|
Wednesday, 28 March 2012 15:56 |
|
In data 10-11 maggio 2012 si terrà presso l’Istituto Superiore di Sanità a Roma il “Convegno Nanomateriali e Salute”
Il Convegno è stato organizzato dal gruppo di lavoro “Nanomateriali e Salute”, recentemente costituito in ISS, per illustrare le attività interdisciplinari dell’Istituto in risposta alla sfida che si sta aprendo, per il mondo scientifico ed istituzionale, verso un equilibrio tra l’introduzione di materiali innovativi e la necessità di assicurare un alto livello di protezione per l’individuo e l’ambiente.
E’ possibile effettuare l’iscrizione (gratuita) entro il 27 aprile 2012 mentre la deadline per l'invio di abstract per la sessione poster al convegno è fissata per il 6 aprile 2012.
Maggiori informazioni saranno disponibili sul sito dedicato al Convegno http://www.nanomaterialiesalute.it |
|
|
Baron de Cartier and Stephan Schmidheiny sentenced to 16 years prison |
|
|
|
|
Written by Francesco Turci
|
|
Thursday, 01 March 2012 17:45 |
 The Eternit trial and verdict: the essence. A verdict of historic importance Stephan Schmidheiny (65) used to be the owner of the Swiss-Belgian industrial group Eternit (ETEX), which was in turn a major shareholder of the Italian subsidiary of Eternit between 1976 and 1986. The Belgian Baron Jean-Louis de Cartier de Marchienne (90) was a director and minority shareholder of Eternit Italy. Today,… Read more: http://asbestosinthedock.ning.com/forum/topic/show?id=2549320%3ATopic%3A23082Read the sentence (in Italian). |
|
|
Written by Ivana Fenoglio
|
|
Friday, 28 October 2011 14:17 |
|

A REVIEW ON THE MECHANISMS OF INORGANIC NANOPARTICLES/BIOFLUIDS INTERACTIONS
A deep knowledge of the processes occurring when a nanoparticle cames in contact with the biological fluids at a molecular level is extremely important in both toxicological and pharmaceutical fields. The fate of a nanoparticle in the body and the toxic or beneficial response of cells to it are, in fact, strictly dependent by the early processes occurring at the nanoparticle surface/biofluid interface. The comprehension of such processes is still at the early stages.
Ivana Fenoglio has been invited to review the stat-of-the-art of understanding inorganic surfaces/macrobiomolecules interaction in ADDR (I. Fenoglio, B. Fubini, E. Ghibaudi, F. Turci, Multiple aspects of the interaction of biomacromolecules with inorganic surfaces Advanced Drug Delivery Reviews 2011, 63, 1186-1209). Read the abstract.
|
|
Read more...
|
|
|
|
|